[Anti-N-methyl-D-aspartate receptor encephalitis:clinical analysis of 11 cases]

Zhonghua Yi Xue Za Zhi. 2015 Sep 15;95(35):2857-60.
[Article in Chinese]

Abstract

Objective: To analyze the clinical manifestation, laboratory findings, radiological data of anti-N-methyl-D-aspartate (NMDA) receptor encephalitis.

Methods: The clinical manifestation, laboratory findings, radiological data of eleven patients with anti-NMDA receptor encephalitis were analyzed.

Results: Main symptoms included epilepsy presented in 9 cases, psychiatric symptom in 7 cases, dyskinesia in 5 cases, autonomic dysfunction in 3 cases. The anti-NMDA receptor antibody was found in all the patients' cerebrospinal fluid (CSF). No teratoma was detected in any of the patients, and 1 case had lung cancer. All the patients received immune therapy. And at discharge, 4 cases recuperated generally, 7 cases had different degrees of dysfunction. After telephone follow-up of 1-18 months, 1 case was lost, 3 cases had complete recovery, and 7 cases had different degrees of sequela.

Conclusion: When Patients without mental illness history presents with unexplained mental symptoms accompanied by seizures, memory impairment, disturbance of consciousness, movement disorders, autonomic dysfunction and other symptoms, anti-NMDA receptor antibodies studies in both serum and CSF should be done as early as possible in order to facilitate early diagnosis, early treatment and improve the prognosis.

MeSH terms

  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis*
  • Antibodies
  • Early Detection of Cancer
  • Epilepsy
  • Humans
  • Mental Disorders
  • Movement Disorders
  • Prognosis
  • Receptors, N-Methyl-D-Aspartate
  • Seizures
  • Teratoma

Substances

  • Antibodies
  • Receptors, N-Methyl-D-Aspartate